Ambiq Micro, Inc.
NYSE:AMBQSemiconductors
+$5.10 today
- Market cap
- $1.14B
- Beta
- 5.68
- P/E (TTM)
- -44.8
- EPS (TTM)
- -$1.88
Volume 0.30M
Average 0.58M
AMBQ Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Ambiq Micro, Inc.NYSE: AMBQ
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of $10.17M (cash outflow) rose 22.8% year over year, ahead of the -0.5% change in trailing-twelve-month net income. Sequentially, it fell 4.8% from the prior quarter.
Context
- Net income amounted to 50.3% of revenue in FY2025, down 1.9 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of -$3.29M (-91.0%) for the fiscal year ending Dec 2026, a slowdown from the -8.1% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$10.17M-4.8% QoQ
- Last fiscal yearDec 2025
- -$36.46M-8.1% YoY
- LTMMar 2026
- -$38.35M-0.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +22.8% | -29.4% | -52.2 pp |
| 1 year | -8.1% | -91.0% | -82.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (36.46M) USD
- Year-over-year change
- +8.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (36.46M) | +8.1% |
| FY2024 | 2024-12-31 | (39.66M) | +21.2% |
| FY2023 | 2023-12-31 | (50.33M) | — |
| FY2021 | 2021-12-31 | (25.34M) | -0.5% |
| FY2020 | 2020-12-31 | (25.22M) | — |
Net Income vs competitors
How AMBQ compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -0.5% is the 5th highest of 11, against a peer median of -12.7%.
- Net income amounts to 46.9% of revenue for AMBQ, versus a peer median of 28.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.58B USD | +391.1% | +86.0% | 222.2% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥150.96M CNY | -47.8% | -67.2% | — |
| LTM Mar 2026 | $81.8M USD | -56.5% | +25.5% | 202.7% | |
| LTM Mar 2026 | $81.65M USD | +82.9% | +44.1% | 5784.6% | |
| LTM Apr 2026 | $55.46M USD | -25.0% | -17.5% | 17.4% | |
| LTM Mar 2026 | $42.63M USD | -8.9% | -20.7% | 28.4% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $38.35M USD | -0.5% | — | 46.9% |
| LTM Mar 2026 | $34.58M USD | +6.9% | -32.3% | 44.9% | |
| LTM Mar 2026 | $25M USD | -16.6% | -17.4% | 10.1% | |
| LTM Mar 2026 | $19.65M USD | -94.2% | -60.8% | 6.5% | |
| LTM Jun 2026 | $6.03M USD | +123.0% | — | 4.8% | |
| Peer median (excluding AMBQ) | — | -12.7% | -17.5% | 28.4% | |
Competitors are the stored peer set for AMBQ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2020 Dec 2020 | FY2021 Dec 2021 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.22M) | (25.34M) | (50.33M) | (39.66M) | (36.46M) |
| Depreciation & Amortization | 1.93M | 2.61M | 7.72M | 6.25M | 7.22M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 702K | 1.29M | 2.62M | 5.17M | 6.84M |
| Change in Working Capital | (16.89M) | (36.58M) | 12.91M | 5.11M | 3.47M |
| Accounts Receivables | (136K) | (10.88M) | (2.98M) | 1.75M | 3.23M |
| Inventory | (3.61M) | (26.46M) | 15.16M | 6.04M | (2.13M) |
| Accounts Payables | (1.55M) | 8.23M | (3.94M) | 821K | 4.2M |
| Other Working Capital | (11.59M) | (7.46M) | 4.67M | (3.51M) | (1.82M) |
| Other Non-Cash Items | 4.84M | 5.14M | 125K | 1.7M | (753K) |
| Operating Cash Flow | (34.64M) | (52.88M) | (26.96M) | (21.43M) | (19.69M) |
| Capital Expenditures | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (1.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (1.96M) | 0 | (2.56M) | (3.07M) | (6.1M) |
| Investing Cash Flow | (4.59M) | (4.62M) | (3.02M) | (3.73M) | (7.44M) |
| Debt Repayment | 8.77M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 58.84M | 109.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.35M) | 354K | 516K | 0 | (2.83M) |
| Financing Cash Flow | 94.07M | 18.2M | 31.77M | 58.84M | 106.38M |
| Effect of Forex Changes | (53K) | 176K | (254K) | (24K) | 43K |
| Net Change in Cash | 54.78M | (39.13M) | 1.54M | 33.66M | 79.29M |
| Free Cash Flow | (39.23M) | (57.5M) | (29.98M) | (25.16M) | (21.03M) |
Ambiq Micro, Inc.
NYSE:AMBQ
Intrinsic Alpha fair value
Locked
Current Price
$45.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.